What the review covers
01
Evaluating submissions against relevant artefacts
02
Producing a structured output
03
Providing a clear outcome with rationale
04
Identifying required actions for clinical and clinical safety SMEs
Who this is for
Health technology manufacturers preparing for DCB 0129 compliance, hazard assessment, or Clinical Safety Case Report documentation — including suppliers preparing for a DTAC assessment, where the review directly evidences the "Clinically Safe" criterion. NHS organisations needing DCB 0160 deployment safety assurance, procurement review, or board-level AI governance support. International health systems embedding safety standards across borders.
Why an independent review
This isn't a generic audit run from a checklist. The review is carried out by practitioners who have operated inside DCB 0129 and DCB 0160 at a national level — not just advised on them — so the output reflects what demonstrably good practice looks like in the field, not just what the paperwork says.